← PFIZER INC
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | ($716.0m) |
($879.0m)
-22.77%
|
($983.0m)
-11.83%
|
($1.3b)
-37.13%
|
($1.4b)
-2.08%
|
$7.7b
+656.10%
|
$8.5b
+11.57%
|
$7.6b
-11.19%
|
$8.4b
+10.63%
|
$9.3b
+10.47%
|
$63.7b
+587.41%
|
|
| Interest Revenue (Expense), Net | ($716.0m) | ($879.0m) | ($983.0m) | ($1.3b) | ($1.4b) | ($1.3b) | ($987.0m) | ($585.0m) | ($2.5b) | ($2.1b) | — | |
| Cost of Revenue | $12.3b |
$11.2b
-8.83%
|
$11.2b
+0.07%
|
$10.2b
-9.15%
|
$8.7b
-14.94%
|
$30.8b
+254.59%
|
$34.3b
+11.43%
|
$25.0b
-27.34%
|
$17.9b
-28.46%
|
$16.1b
-9.99%
|
$17.1b
+6.32%
|
|
| Cost of sales | $12.3b |
$11.2b
-8.83%
|
$11.2b
+0.07%
|
$10.2b
-9.15%
|
$8.7b
-14.94%
|
$30.8b
+254.59%
|
$34.3b
+11.43%
|
$25.0b
-27.34%
|
$17.9b
-28.46%
|
$16.1b
-9.99%
|
$17.1b
+6.32%
|
|
| Gross Profit (Calculated) | $40.5b |
$41.3b
+2.00%
|
$42.4b
+2.65%
|
$41.5b
-2.05%
|
$33.2b
-20.02%
|
$50.5b
+51.94%
|
$66.0b
+30.75%
|
$26.0b
-60.66%
|
$45.8b
+76.33%
|
$46.5b
+1.61%
|
— | |
| Acquired in-process research and development expenses | — | — | — | — | $684.0m | $3.5b | $953.0m | $194.0m | $108.0m | $1.6b | — | |
| Research and development expenses | $7.9b | $7.7b | $8.0b | $8.7b | $9.4b | $13.8b | $11.4b | $10.7b | $10.8b | $10.4b | $11.1b | |
| Selling, General and Administrative Expense | $14.8b | $14.8b | $14.5b | $14.3b | $11.6b | $12.7b | $13.7b | $14.8b | $14.7b | $13.8b | $13.7b | |
| Amortization of Intangible Assets | $4.1b | $4.8b | $4.9b | $4.6b | $3.4b | $3.7b | $3.6b | $4.7b | $5.3b | $4.9b | — | |
| Restructuring and Related Cost, Incurred Cost | — | — | $1.4b | $967.0m | — | — | — | — | — | — | — | |
| Restructuring charges and certain acquisition-related costs | $1.7b | $487.0m | $1.0b | $747.0m | $600.0m | $802.0m | $1.4b | $2.9b | $2.4b | $1.6b | — | |
| Interest Expense | $1.2b | $1.3b | $1.3b | $1.6b | $1.4b | $1.3b | $1.2b | $2.2b | $3.1b | $2.7b | $2.7b | |
| Debt Securities, Realized Gain (Loss) | — | — | ($141.0m) | $0 | $0 | — | — | — | — | — | — | |
| Equity Securities, FV-NI, Realized Gain (Loss) | — | — | $109.0m | $25.0m | $24.0m | $80.0m | $126.0m | $1.8b | $1.1b | ($35.0m) | — | |
| Gain (Loss) Related to Litigation Settlement | — | ($240.0m) | ($157.0m) | ($554.0m) | ($28.0m) | ($182.0m) | ($230.0m) | ($474.0m) | ($567.0m) | ($1.1b) | — | |
| Other Nonoperating Income (Expense) | ($3.7b) | ($1.3b) | ($2.1b) | ($3.6b) | ($669.0m) | $4.9b | ($217.0m) | $835.0m | ($4.4b) | ($6.7b) | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Domestic | ($8.5b) | ($6.9b) | ($4.4b) | $7.9b | ($2.5b) | $6.1b | $5.0b | ($4.4b) | ($637.0m) | $776.0m | $4.2b | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $8.4b | $12.3b | $11.9b | $17.7b | $7.5b | $24.3b | $34.7b | $1.1b | $8.0b | $7.5b | $4.2b | |
| Current Income Tax Expense (Benefit) | — | — | — | — | — | — | — | — | — | $1.9b | ($164.0m) | |
| Income Tax Expense (Benefit) | $1.1b | ($9.0b) | $706.0m | $1.4b | $477.0m | $1.9b | $3.3b | ($1.1b) | ($28.0m) | ($266.0m) | ($164.0m) | |
| Net Income (Loss) Attributable to Parent | $7.2b |
$21.3b
+195.33%
|
$11.2b
-47.66%
|
$16.3b
+45.91%
|
$9.6b
-40.91%
|
$22.0b
+128.57%
|
$31.4b
+42.74%
|
$2.1b
-93.25%
|
$8.0b
+279.00%
|
$7.8b
-3.24%
|
$4.3b
-44.23%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $7.2b |
$21.3b
+195.36%
|
$11.2b
-47.66%
|
$16.3b
+45.91%
|
$9.6b
-40.90%
|
$22.0b
+128.57%
|
$31.4b
+42.74%
|
$2.1b
-93.25%
|
$8.0b
+279.00%
|
$7.8b
-3.24%
|
$4.3b
-44.23%
|
|
| Less: Net income attributable to noncontrolling interests | $31.0m | $47.0m | $36.0m | $29.0m | $36.0m | $45.0m | $35.0m | $39.0m | $31.0m | $41.0m | — | |
| Net income before allocation to noncontrolling interests | $7.2b | $21.4b | $11.2b | $16.3b | $9.7b | $22.0b | $31.4b | $2.2b | $8.1b | $7.8b | — | |
| Preferred Stock Dividends, Income Statement Impact | $1.0m | $1.0m | $1.0m | $1.0m | $0 | $0 | — | — | — | — | — | |
| Discontinued operations––net of tax (in dollars per share) | $0.00 | $0.00 | $0.00 | $0.00 | $0.47 | ($0.08) | $0.00 | $0.00 | $0.00 | $0.00 | — | |
| Earnings Per Share, Basic | $1.12 | $3.39 | $1.80 | $2.77 | $1.73 | $3.92 | $5.59 | $0.38 | $1.42 | $1.37 | $0.77 | |
| Earnings Per Share, Diluted | $1.11 | $3.34 | $1.77 | $2.72 | $1.71 | $3.85 | $5.47 | $0.37 | $1.41 | $1.36 | $0.76 | |
| Income (Loss) from Continuing Operations, Per Basic Share | $1 | $4 | $2 | $3 | $1 | $4 | $6 | $0 | $1 | $1 | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $1 | $4 | $2 | $3 | $1 | $4 | $5 | $0 | $1 | $1 | — | |
| Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) | $1 | $4 | $2 | $3 | $1 | $4 | $5 | $0 | $1 | $1 | — | |
| Common Stock, Dividends, Per Share, Declared | $1.08 | $1.15 | $1.31 | $1.39 | $1.53 | $1.57 | $1.61 | $1.65 | $1.69 | $1.72 | — | |
| Weighted Average Number of Shares Outstanding, Basic | 6.4b | 6.3b | 6.2b | 5.9b | 5.6b | 5.6b | 5.6b | 5.6b | 5.7b | 5.7b | 5.7b | |
| Weighted-average shares––basic (in shares) | $6.1b | $6.0b | $5.9b | $5.6b | $5.6b | $5.6b | $5.6b | $5.6b | $5.7b | $5.7b | — | |
| Weighted-average shares––diluted (in shares) | $6.2b | $6.1b | $6.0b | $5.7b | $5.6b | $5.7b | $5.7b | $5.7b | $5.7b | $5.7b | — | |
| Weighted Average Number of Shares Outstanding, Diluted | 6.5b | 6.4b | 6.3b | 6.0b | 5.6b | 5.7b | 5.7b | 5.7b | 5.7b | 5.7b | 5.7b | |
| Additional Financial Items | ||||||||||||
| Discontinued operations––net of tax | $17.0m | $2.0m | $10.0m | $4.0m | $2.6b | ($434.0m) | $6.0m | ($15.0m) | $11.0m | $25.0m | — | |
| Income from continuing operations | $7.2b | $21.4b | $11.2b | $16.3b | $7.0b | $22.5b | $31.4b | $2.2b | $8.1b | $7.8b | — | |
| Income from continuing operations before provision/(benefit) for taxes on income | $8.4b | $12.3b | $11.9b | $17.7b | $7.5b | $24.3b | $34.7b | $1.1b | $8.0b | $7.5b | — | |
| Other (income)/deductions––net | $3.7b | $1.3b | $2.1b | $3.6b | $669.0m | ($4.9b) | $217.0m | ($835.0m) | $4.4b | $6.7b | — | |
| Provision/(benefit) for taxes on income | $1.1b | ($9.0b) | $706.0m | $1.4b | $477.0m | $1.9b | $3.3b | ($1.1b) | ($28.0m) | ($266.0m) | — | |
| Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax | $16.0m | ($1.0m) | $10.0m | $4.0m | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $7.2b | $21.3b | $11.1b | $16.3b | $7.0b | $22.4b | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $7.2b | $21.4b | $11.2b | $16.3b | $7.0b | $22.5b | $31.4b | $2.2b | $8.1b | $7.8b | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | $17.0m | $2.0m | $10.0m | $4.0m | $2.6b | ($434.0m) | $6.0m | ($15.0m) | $11.0m | $25.0m | — | |
| Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $17.0m | $2.0m | $10.0m | $4.0m | $2.6b | ($434.0m) | $6.0m | ($15.0m) | $11.0m | $25.0m | — | |
| Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component | — | — | ($288.0m) | $64.0m | ($236.0m) | ($2.5b) | ($849.0m) | ($610.0m) | $154.0m | ($678.0m) | — |
Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.